CYCS and cancer: Moreover, 2-ME2 was found to stimulate cytochrome C release in many cancer cells including prostate cancer cells [56], pancreatic cancer cells [57], human chondrosarcoma cells [58], human acute T lymphoblastic leukemia CEM cells [59], and fibroblasts [60].